Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.23.3
Shareholders' Deficit (Tables)
9 Months Ended
Sep. 30, 2023
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Activity Related to Non-Vested Shares The following table summarizes activity related to non-vested shares:
    Number of
Non-Vested
Shares
    Weighted
Average
Grant Date
Fair Value
 
Non-vested, December 31, 2022     16,970,120     $ 0.119  
Granted    
-
     
-
 
Shares vested     (2,000,000 )     0.021  
Non-vested, September 30, 2023     14,970,120     $ 0.132  
Stock Options [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock option activities Stock option activities for the nine months ended September 30, 2023 are summarized as follows:
    Number of
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Balance Outstanding, December 31, 2022     8,445,698     $ 0.40       3.43      
     -
 
Exercised    
-
     
-
     
-
     
-
 
Balance Outstanding, September 30, 2023     8,445,698     $ 0.40       2.60     $
-
 
Exercisable, September 30, 2023     8,445,698     $ 0.40       2.60     $
-
 
Warrant [Member]  
Shareholders' Deficit (Tables) [Line Items]  
Schedule of Stock option activities Warrant activities for the nine months ended September 30, 2023 are summarized as follows:
    Number of
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term (Years)
    Aggregate
Intrinsic
Value
 
Balance Outstanding December 31, 2022     34,000,000     $ 0.011       3.73     $
     -
 
Granted    
-
     
-
     
-
     
-
 
Balance Outstanding September 30, 2023     34,000,000     $ 0.011       2.99     $
-
 
Exercisable, September 30, 2023     34,000,000     $ 0.011       2.99     $
-